| Alexander Lee Matz, MD | |
|
405 Silverside Road, Ste 104, Wilmington, DE 19809-1768 | |
| (844) 365-7246 | |
| (844) 516-0080 |
| Full Name | Alexander Lee Matz |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 12 Years |
| Location | 405 Silverside Road, Ste 104, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861755514 | NPI | - | NPPES |
| 103612207 | Medicaid | PA | |
| 578018700 | Medicaid | MD | |
| 250533585 | Medicaid | DE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Interventional Pain Spine Llc | 6507040078 | 28 |
| Center For Interventional Pain Spine Llc | 6507040078 | 28 |
| Center For Interventional Pain Spine Llc | 6507040078 | 28 |
News Archive
The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.
InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.
StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.
Even successful methods for diagnosing, treating and caring for people who are suffering from cancer are not enough without effective, practical tools and guidance for putting those methods into practice.
› Verified 4 days ago
| Entity Name | Center For Interventional Pain Spine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144527003 PECOS PAC ID: 6507040078 Enrollment ID: O20210928000463 |
News Archive
The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.
InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.
StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.
Even successful methods for diagnosing, treating and caring for people who are suffering from cancer are not enough without effective, practical tools and guidance for putting those methods into practice.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexander Lee Matz, MD 291 Carter Dr Ste A, Middletown, DE 19709-5845 Ph: (844) 365-7246 | Alexander Lee Matz, MD 405 Silverside Road, Ste 104, Wilmington, DE 19809-1768 Ph: (844) 365-7246 |
News Archive
The next advance in treating major depression may relate to a group of brain chemicals that are involved in virtually all our brain activity, according to a study published today in Biological Psychiatry.
InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.
StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.
Even successful methods for diagnosing, treating and caring for people who are suffering from cancer are not enough without effective, practical tools and guidance for putting those methods into practice.
› Verified 4 days ago